Status:
COMPLETED
Rosuvastatin and Ischemia Reperfusion
Lead Sponsor:
Radboud University Medical Center
Conditions:
Ischemia
Eligibility:
MALE
18-50 years
Phase:
PHASE2
Brief Summary
Statins, including rosuvastatin, are drugs that lower plasma cholesterol and prevent atherosclerotic disease. Recent preclinical evidence suggests that statins also increase tissue tolerance to ischem...
Eligibility Criteria
Inclusion
- Healthy volunteers (18-50 years of age)
Exclusion
- Hypercholesterolemia
- Hypertension
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
End Date :
August 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00315510
Start Date
April 1 2006
End Date
August 1 2007
Last Update
September 23 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Centre Nijmegen; Radboud University Nijmegen Medical Centre
Nijmegen, Gelderland, Netherlands, 6500 HB